Astellas Receives Worldwide Commercial Rights to Major Preclinical Programme
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 100 (Table of Contents)
Published: 19 Sep-2008
DOI: 10.3833/pdr.v2008.i100.128 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Maxygen has entered into a co-development agreement with Astellas for its protein drug programme...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS